Inherent formulation issues of kinase inhibitors

Keyphrases

• Drug Class 66%
• Drug Solubility 33%
• Formulation Design 33%
• Inhibitor Drug 33%
• Inhibitor Formulations 33%
• Intrinsic Solubility 33%
• Kinase Inhibitor 100%
• Pharmaceutical Formulations 33%
• Physical Mixture 33%
• Salt Form 33%
• Small Molecular 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Bioavailability 33%
• Drug Solubility 33%
• Formulation Design 33%
• Phosphotransferase Inhibitor 100%
• Table Salt 33%